A living biobank of breast cancer organoids captures disease heterogeneity

Sachs, Norman, de Ligt, Joep, Kopper, Oded, Gogola, Ewa, Bounova, Gergana, Weeber, Fleur, Balgobind, Anjali Vanita, Wind, Karin +23 more·2018·Cell

Cited by (1,002)

Items 301–400 of 1,002

  1. Towards manufacturing of human organoids
    Aswathi Ashok, Deepak Choudhury, Yu Fang, Walter Hunziker · 2019 · Biotechnology Advances
  2. Organoid technology in cancer precision medicine
    Xinyi Xia, Fei Li, Juan He, Rebiguli Aji, Dong Gao · 2019 · Cancer Letters
  3. Establishment of Pancreatic Organoids from Normal Tissue and Tumors
    Else Driehuis, Ana Gracanin, Robert G.J. Vries, Hans C. Clevers, Sylvia F. Boj · 2020 · STAR Protocols
  4. Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures
    Nilgun Tasdemir, Emily A. Bossart, Zheqi Li, Li Zhu, Matthew J. Sikora, Kevin M. Levine, Britta M. Jacobsen, George C. Tseng, Nancy E. Davidson, Steffi Oesterreich · 2018 · Cancer Research
  5. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application
    MoonSun Jung, Sarah Ghamrawi, Eric Yiwei Du, J. Justin Gooding, Maria Kavallaris · 2022 · Advanced Healthcare Materials
  6. GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids
    Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny L. Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark N. Adams, Laura Jane Bray et al. · 2023 · Pharmaceutics
  7. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
    Lidwien Paula Smabers, G. Emerens Wensink, Carla S. Veríssimo, Esmee Koedoot, Katerina-Chara Pitsa, Maarten A. Huismans, Celia Higuera Barón, Mayke Doorn, Liselot Valkenburg‐van Iersel, Geert A. Cirkel et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  8. Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
    Hao Zhang, Li Fu, Xinwen Leiliang, Chunrun Qu, Wantao Wu, Rong Wen, Ning Huang, Qiuguang He, Quan Cheng, Guodong Liu et al. · 2024 · 癌症:英文版
  9. Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
    Bethany R. Bareham, Nikitas Georgakopoulos, Alba Matas‐Céspedes, Michelle Curran, Kourosh Saeb‐Parsy · 2021 · Cancer Immunology Immunotherapy
  10. Organoid Technology: Current Standing and Future Perspectives
    Laleh Shariati, Yasaman Esmaeili, Shaghayegh Haghjooy Javanmard, Elham Bidram, Abbas Amini · 2021 · Stem Cells
  11. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
    Ergang Wang, Kun Xiang, Yun Zhang, Xiao‐Fan Wang · 2022 · Journal of the National Cancer Center
  12. Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer
    Ganfei Xu, Rui Huang, Reziya Wumaier, Jiacheng Lyu, Minjing Huang, Yaya Zhang, Qingjian Chen, Wenting Liu, Mengyu Tao, Junjian Li et al. · 2024 · Cancer Research
  13. LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
    Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández‐Prat, David Casadevall, Sílvia Menéndez, Daniel Dan Liu et al. · 2022 · Nature Cancer
  14. Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
    Xiaoxue Ren, Weikang Chen, Qingxia Yang, Xiaoxing Li, Lixia Xu · 2022 · Journal of Gastroenterology and Hepatology
  15. Harnessing Tumor Evolution to Circumvent Resistance
    Katherine Lee McNamara, Christina N. Curtis · 2018 · Trends in Genetics
  16. Characterization of organoid cultured human breast cancer
    Nadine Goldhammer, Jiyoung Kim, Vera Timmermans Wielenga, OLE WILLIAM PETERSEN · 2019 · Breast Cancer Research
  17. Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
    Nuzhat Ahmed, Elif Kadife, Ali Raza, Mary K. Short, Paul T. Jubinsky, George Kannourakis · 2020 · Cells
  18. Novel patient-derived preclinical models of liver cancer
    Erin R. Bresnahan, Pierluigi Ramadori, Mathias F Heikenwälder, Lars Zender, Amaia Lujambio · 2020 · Journal of Hepatology
  19. Organoids to study immune functions, immunological diseases and immunotherapy
    Wenrui Ye, Cong Luo, Chenglong Li, Jing Huang, Fangkun Liu · 2020 · Cancer Letters
  20. Advances in biofabrication techniques for collagen-based 3D in vitro culture models for breast cancer research
    John Redmond, Helen O. McCarthy, Paul Buchanan, Tanya J. Levingstone, Nicholas Dunne · 2021 · Materials Science and Engineering C
  21. High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing
    Xiaojun Yan, Lyu Zhou, Zhaozhao Wu, Xun Wang, Xiuyuan Chen, Fan Yang, Yanan Guo, Min Wu, Yuyang Chen, Wenjing Li et al. · 2018 · Biomaterials
  22. Recent advances in preclinical models for lung squamous cell carcinoma
    Yuanwang Pan, Han Han, Kristen E. Labbe, Hua Zhang, Kwok‐Kin Wong · 2021 · Oncogene
  23. Patient-Derived Organoids as a Model for Cancer Drug Discovery
    Colin J. Rae, Francesco Amato, Chiara Braconi · 2021 · International Journal of Molecular Sciences
  24. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis
    Yiyu Chen, Jingyu Ge, Siyuan Zhu, Zhi‐Ming Shao, Ke‐Da Yu · 2022 · Nature Communications
  25. Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models
    Xiaohui Si, Lu Xiao, Christine E. Brown, Dongrui Wang · 2022 · International Journal of Molecular Sciences
  26. A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
    Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, Samantha Sharma, Tao Yu, Ishara Moulana, Sheng Liu, Jun Wan, Paul R. Territo, Mateusz Opyrchal et al. · 2023 · Advanced Science
  27. Moving Breast Cancer Therapy up a Notch
    Erik Mollen, Jonathan Ient, Vivianne C. G. Tjan‐Heijnen, Liesbeth Jorinne Boersma, Lucio Miele, Marjolein L. Smidt, Marc Vooijs · 2018 · Frontiers in Oncology
  28. Present Application and Perspectives of Organoid Imaging Technology
    Fei, Keyi, Zhang, Jinze, Yuan, Jin, Xiao, Peng · 2022 · Bioengineering
  29. Organoid models of glioblastoma: advances, applications and challenges.
    Chaocai Zhang, Ming-Zhu Jin, Jiannong Zhao, Juxiang Chen, Weilin Jin · 2020 · PubMed Central
  30. Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
    S.Y. Jeong, Minyong Kang · 2023 · International Journal of Molecular Sciences
  31. Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis
    Kevin P. Roarty, Gloria Vittone Echeverria · 2021 · Frontiers in Oncology
  32. Retracted: Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
    Claire Vennin, Chiara Maria Cattaneo, Leontien Bosch, Serena Vegna, Xuhui Ma, Hugo G.J. Damstra, Moreno Martinovic, Efi Tsouri, Mila Ilić, Leyla Azarang et al. · 2023 · Cancer Cell · Retracted
  33. Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications
    Hyeon Ryoo, Hannah Kimmel, Evi Rondo, Gregory H. Underhill · 2023 · Bioengineering & Translational Medicine
  34. Organoid Center Strategies for Accelerating Clinical Translation
    Takanori Takebe, James M. Wells, Michael A. Helmrath, Aaron M. Zorn · 2018 · Cell stem cell
  35. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Fiona Helen Blackhall, Kristopher K. Frese, Kathryn Simpson, Elaine Kilgour, Gerard Brady, Caroline Dive · 2018 · The Lancet Oncology
  36. Organoid Models for Cancer Research
    Hans C. Clevers, David A. Tuveson · 2019 · Annual Review of Cancer Biology
  37. Microdissected “cuboids” for microfluidic drug testing of intact tissues
    Horowitz, Lisa F., Rodriguez, Adan D., Au-Yeung, Allan, Bishop, Kevin W., Barner, Lindsey A., Mishra, Gargi, Raman, Aashik, Delgado, Priscilla, Liu, Jonathan T. C., Gujral, Taranjit S. et al. · 2021 · Lab on a Chip
  38. Tumor organoid biobank-new platform for medical research
    Xuexue Xie, Xinyu Li, Wei Song · 2023 · Scientific Reports
  39. Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
    Ryan C. Smith, Viviane S. Tabar · 2018 · Cell stem cell
  40. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation
    Peiyuan Zhang, Yingjie Liu, Cheng Lian, Xuan Duc Cao, Yuan Wang, Xiaoxun Li, Min Cong, Pu Tian, Xue Zhang, Gang Wei et al. · 2020 · Nature Communications
  41. Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation
    Benjamin E. Mead, Kazuki Hattori, Lauren E. Levy, Shinya Imada, Norihiro Goto, Marko Vukovic, Daphne Sze, Conner Kummerlowe, Juan David Matute, Jinzhi Duan et al. · 2022 · Nature Biomedical Engineering
  42. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
    Jérôme Cartry, Sabrina Bedja, Alice Boilève, Jacques R.R. Mathieu, Emilie Gontran, Maxime Annereau, Bastien Job, Ali Mouawia, Pierre Mathias, Thierry de Baère et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  43. Bioengineering Organs for Blood Detoxification
    Cécile Legallais, DooLi Kim, Sylvia M. Mihaila, Milos Mihajlovic, Marina Figliuzzi, Barbara Bonandrini, Simona Salerno, Fjodor A. Yousef Yengej, Maarten B. Rookmaaker, Natalia Sánchez Romero et al. · 2018 · Advanced Healthcare Materials
  44. Organoid models of the tumor microenvironment and their applications
    Tao Xia, Wen‐Lin Du, Xiaoyi Chen, You-Ni Zhang · 2021 · Journal of Cellular and Molecular Medicine
  45. Acoustic Droplet Printing Tumor Organoids for Modeling Bladder Tumor Immune Microenvironment within a Week
    Zhiyi Gong, Lanxiang Huang, Xuan Tang, Keke Chen, Zhuhao Wu, Lingling Zhang, Yue Sun, Yu Xia, Hui Chen, Yongchang Wei et al. · 2021 · Advanced Healthcare Materials
  46. Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
    Lichan Chen, Xiafei Wei, Dayong Gu, Yong Xu, Hongzhong Zhou · 2023 · Cancer Letters
  47. Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness
    Behzad Mansoori, Pascal H. G. Duijf, Ali Mohammadi et al. · 2020 · Expert Opinion on Therapeutic Targets
  48. Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
    Roberta Azzarelli · 2020 · Frontiers in Cell and Developmental Biology
  49. Organoid models for mammary gland dynamics and breast cancer
    Vasudha Srivastava, Tyler R. Huycke, Kiet T. Phong, Zev J. Gartner · 2020 · Current Opinion in Cell Biology
  50. The frontier of live tissue imaging across space and time
    Qiang Huang, Aliesha Garrett, Shree Bose, Stephanie J. Blocker, Anne C. Rios, Hans C. Clevers, Xiling Shen · 2021 · Cell stem cell
  51. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
    Na Zhao, Reid Trenton Powell, Xueying Yuan, Goeun Bae, Kevin P. Roarty, Fabio Stossi, Martina Strempfl, Michael Joseph Toneff, Hannah L. Johnson, Sendurai A. Mani et al. · 2021 · Nature Communications
  52. Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids
    Beatriz S. Moura, Maria V. Monteiro, Luís P. Ferreira, Pedro Lavrador, Vítor M. Gaspar, João Filipe Mano · 2022 · Advanced Functional Materials
  53. The role of organoids in cancer research
    Zhen Fang, Peijuan Li, Fengying Du, Liang Shang, Leping Li · 2023 · Experimental Hematology and Oncology
  54. Tumor organoids: From inception to future in cancer research
    Liang Yang, Shuo Yang, Xinyu Li, Bowen Li, Yan Li, Xiaodong Zhang, Yingbo Ma, Xueqiang Peng, Hongyuan Jin, Qing Fan et al. · 2019 · Cancer Letters
  55. Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy
    Biswadeep Nayak, Gowri Manohari Balachander, Sathish Manjunath, Annapoorni Rangarajan, Kaushik Chatterjee · 2019 · Colloids and Surfaces B Biointerfaces
  56. Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes following Chemotherapeutic Treatment
    Rebekah M. Engel, Wing Hei Chan, David K. Nickless, Sara Hlavca, Elizabeth Richards, Genevieve Kerr, Karen Oliva, Paul John McMurrick, Thierry Jardé, Helen E. Abud · 2020 · Journal of Clinical Medicine
  57. A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
    James A. Saltsman, William J. Hammond, Nicole J.C. Narayan, David Requena, Helmuth Gehart, Gadi Lalazar, Michael P. LaQuaglia, Hans C. Clevers, Sanford M. Simon · 2020 · Cancers
  58. Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
    Enrique Javier Arenas, Alex Martínez-Sabadell, Irene Rius Ruiz, Macarena Román Alonso, Marta Escorihuela, Antonio Luque-García, Carlos Alberto Fajardo, Alena Gros, Christian Klein, Joaquı́n Arribas · 2021 · Nature Communications
  59. Discovering and validating cancer genetic dependencies: approaches and pitfalls
    Ann Lin, Jason M. Sheltzer · 2020 · Nature Reviews Genetics
  60. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer
    Ting Wang, Wenjun Pan, Hang Zheng, Hongping Zheng, Zhejun Wang, Jia J. Li, Chu‐Xia Deng, Jun Yan · 2021 · Diseases of the Colon & Rectum
  61. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening
    Flávia Castro, Catarina Leite Pereira, Maria Helena Macedo, Andreia Almeida, Maria José Silveira, Sofia Dias, Ana Patrícia Cardoso, María José Oliveira, Bruno Filipe Carmelino Cardoso Sarmento · 2021 · Advanced Drug Delivery Reviews
  62. Exploiting epigenetic dependencies in ovarian cancer therapy
    Aisling Y. Coughlan, Giuseppe Testa · 2021 · International Journal of Cancer
  63. Organoids in high-throughput and high-content screenings
    Franziska L. Lampart, Dagmar Iber, Nikolaos Doumpas · 2023 · Frontiers in Chemical Engineering
  64. Identification of a mechanogenetic link between substrate stiffness and chemotherapeutic response in breast cancer
    Scott H. Medina, Brian Bush, Maggie Cam, Emily N. Sevcik, Frank W. DelRio‬, Kaustav Nandy, Joel P. Schneider · 2019 · Biomaterials
  65. 3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
    Teresa Franchi-Mendes, Rodrigo Eduardo, Giacomo Domenici, Catarina Brito · 2021 · Cancers
  66. Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells
    Mihir B Doshi, Namgyu Lee, T. Tseyang, Olga Ponomarova, H. Goel, Meghan E. Spears, Rui Li, L. Zhu, Christopher Ashwood, Karl Simin et al. · 2023 · Nature
  67. A comprehensive review of 3D cancer models for drug screening and translational research
    Karthikey Sharma, Sreenath Dey, Rounik Karmakar, Aravind Kumar Rengan · 2023 · Cancer Innovation
  68. Establishment and characterization of patient‐derived organoids from a young patient with cervical clear cell carcinoma
    Yoshiaki Maru, Naotake Tanaka, Keiko Ebisawa, Akiko Odaka, Takahiro Sugiyama, Makiko Itami, Yoshitaka Hippo · 2019 · Cancer Science
  69. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
    Lehang Lin, De‐Chen Lin · 2019 · Cancers
  70. ‘Omics Approaches to Explore the Breast Cancer Landscape
    Joseph Parsons, Chiara Francavilla · 2020 · Frontiers in Cell and Developmental Biology
  71. Organotypic 3D decellularized matrix tumor spheroids for high-throughput drug screening
    Ferreira, Luís P., Gaspar, Vítor M., Mendes, Luís, Duarte, Iola F., Mano, João F. · 2021 · Biomaterials
  72. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer
    Soheila Delgir, Milad Bastami, Khandan Ilkhani, Asma Safi, Farhad Seif, Mohammad Reza Alivand · 2021 · Mutation Research/Reviews in Mutation Research
  73. Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
    Dimitra Georgopoulou, Maurizio Callari, Oscar M. Rueda, Abigail Shea, Alistair G. Martin, Agnese Giovannetti, Fatime Qosaj, Ali A. Dariush, Suet‐Feung Chin, Larissa S. Carnevalli et al. · 2021 · Nature Communications
  74. Cancer organoids: A platform in basic and translational research
    Xin Ma, Qin Lin Wang, Guozheng Li, Hui Li, Shouping Xu, Da Pang · 2023 · Genes & Diseases
  75. Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex
    Chenxi Zhao, Tingting Zhang, Si-Tu Xue, Peitao Zhang, Feng Wang, Yunxuan Li, Ying Liu, Luyao Zhao, Jie Wu, Yechao Yan et al. · 2024 · Cell Metabolism
  76. Advancements in Microphysiological systems: Exploring organoids and organ-on-a-chip technologies in drug development -focus on pharmacokinetics related organs-
    Hiroshi Kimura, Masaki Nishikawa, Naokata Kutsuzawa, Fumiya Tokito, Takuma Kobayashi, Dhimas Agung Kurniawan, Hiroki Shioda, Wenxin Cao, Kenta Shinha, Hiroko Nakamura et al. · 2024 · Drug Metabolism and Pharmacokinetics
  77. YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice
    Jaeoh Park, David Eisenbarth, Wonyoung Choi, Hail Kim, Chan Choi, Dahye Lee, Dae‐Sik Lim · 2020 · Cancer Research
  78. Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
    Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, Layal Ashi, Rawan A Rahman AlHarmi, Noora Hassani · 2024 · Translational Oncology
  79. Organoid of ovarian cancer: genomic analysis and drug screening
    Huidong Liu, Bairong Xia, Mingzhu Jin, Ge Lou · 2020 · Clinical & Translational Oncology
  80. Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
    Xingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
  81. The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
    Lauren M. Granat, Ooha Kambhampati, Stephanie Klosek, Brian Niedzwecki, Kian Parsa, Dong Zhang · 2019 · Animal Models and Experimental Medicine
  82. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
    Lina Ding, Ying Su, Anne Fassl, Kunihiko Hinohara, Xintao Qiu, Nicholas W. Harper, Sung Jin Huh, Noga Bloushtain-Qimron, Bojana Jovanović, Muhammad B. Ekram et al. · 2019 · Nature Communications
  83. Engineered organoids for biomedical applications
    Natan Roberto de Barros, Canran Wang, Surjendu Maity, Arne Peirsman, Rohollah Nasiri, Anna Herland, Menekşe Ermis, Satoru Kawakita, Bruna Gregatti de Carvalho, Negar Hosseinzadeh Kouchehbaghi et al. · 2023 · Advanced Drug Delivery Reviews
  84. Accurate and sensitive mutational signature analysis with MuSiCal
    Hu Jin, D. Gulhan, Benedikt Geiger, Daniel Ben-Isvy, David Geng, Viktor Ljungström, Peter J. Park · 2024 · Nature Genetics
  85. Microphysiological Systems as Enabling Tools for Modeling Complexity in the Tumor Microenvironment and Accelerating Cancer Drug Development
    Hong Nam Kim, Nicole L. Habbit, Chia‐Yi Su, Nakwon Choi, Eun Hyun Ahn, Elizabeth A. Lipke, Deok‐Ho Kim · 2019 · Advanced Functional Materials
  86. Progress in human liver organoids
    Lulu Sun, Lijian Hui · 2020 · Journal of Molecular Cell Biology
  87. Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models
    Katya A. D’Costa, Milena Kosic, Angus Lam, Azeen Moradipour, Yimu Zhao, Milica Radisic · 2020 · Annals of Biomedical Engineering
  88. Bioinformatics and computational approaches for analyzing patient-derived disease models in cancer research
    Deena M.A. Gendoo · 2020 · Computational and Structural Biotechnology Journal
  89. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
    George Sflomos, Koen Schipper, Thijs Koorman, Amanda Fitzpatrick, Steffi Oesterreich, Adrian V. Lee, Jos Jonkers, Valerie G. Brunton, Matthias Christgen, Clare M. Isacke et al. · 2021 · Cancers
  90. Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications
    Steven Donald Forsythe, Hemamylammal Sivakumar, Richard A. Erali, Nadeem Wajih, Wencheng Li, Perry Shen, Edward Allen Levine, Katherine E. Miller, Aleksander Skardal, Konstantinos Ioannis Votanopoulos · 2022 · Annals of Surgical Oncology
  91. S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer
    Hongnan Mo, Xuefeng Liu, Yu Xue, Hongyan Chen, Shichao Guo, Zhangfu Li, Shuang Wang, Caiming Li, Jiashu Han, Ming Fu et al. · 2022 · Molecular Cancer
  92. Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors
    Chun‐Chung Chen, Hong-Wei Li, Yuanliang Wang, Chuan-Chun Lee, Yi-Chun Shen, Ching-Yun Hsieh, Hung‐Lin Lin, Xian-Xiu Chen, Der‐Yang Cho, Ching‐Liang Hsieh et al. · 2022 · Scientific Reports
  93. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
    Dan Shu, Meiying Shen, Kang Li, Xiaojian Han, Han Li, Zhaofu Tan, Yu Wang, Yang Peng, Zhenrong Tang, Chi Qu et al. · 2022 · Annals of Medicine
  94. Personalized Cancer Models for Target Discovery and Precision Medicine
    Carla Grandori, Christopher J. Kemp · 2018 · Trends in cancer
  95. SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
    Xiyu Liu, Wang Jiang, Ding Ma, Li‐Ping Ge, Yun‐Song Yang, Zongchao Gou, Xiao‐En Xu, Zhi‐Ming Shao, Yi‐Zhou Jiang · 2020 · Theranostics
  96. Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
    Hege Fredriksen Berg, Marta Espevold Hjelmeland, Hilde Eide Lien, Heidi Espedal, Tina Fonnes, Aashish Srivastava, Tomasz Stokowy, Elin Strand, Olivera Bozickovic, Ingunn M. Stefansson et al. · 2021 · Communications Medicine
  97. Rapid tissue prototyping with micro-organospheres
    Zhaohui Wang, Matteo Boretto, Rosemary Millen, Naveen R. Natesh, Elena S. Reckzeh, Carolyn Hsu, Marcos Negrete, Haipei Yao, W. B. Quayle, Brook E. Heaton et al. · 2022 · Stem Cell Reports
  98. Recreating the extracellular matrix: novel 3D cell culture platforms in cancer research
    Konstantina Kyriakopoulou, Christos Koutsakis, Zoi Piperigkou, Nikos K. Karamanos · 2023 · FEBS Journal
  99. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer
    Xingfeng He, Yan J. Jiang, Long Zhang, Yaqi Li, Xiang Hu, Guoqiang Hua, Sanjun Cai, Shaobo Mo, Junjie Peng · 2023 · Frontiers in Bioengineering and Biotechnology
  100. Implementing cell-free DNA of pancreatic cancer patient–derived organoids for personalized oncology
    Zahra Dantes, Hsi-Yu Yen, Nicole Pfarr, Christof Winter, Katja Steiger, Alexander Muckenhuber, Alexander Hennig, Sebastian Lange, Thomas Engleitner, Rupert Öllinger et al. · 2020 · JCI Insight